prof. dr. apr. Olivier De Wever
- ORCID iD
- 0000-0002-5453-760X
Show
Sort by
-
Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study
-
- Journal Article
- A1
- open access
Pelophen B is a non-taxoid binding microtubule-stabilizing agent with promising preclinical anticancer properties
-
Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab : insights from the phase II PRIMMO trial
-
- Journal Article
- A1
- open access
Quantitative determination and subcellular mapping of Pt-based drugs in single breast tumour cells via laser ablation-ICP-mass spectrometry
-
An evaluation of the analytical and biological robustness of a method for quantifying iron in individual red blood cells via single-cell tandem ICP-mass spectrometry
-
- Journal Article
- A1
- open access
Dual-ligand PROTACS mediate superior target protein degradation in vitro and therapeutic efficacy in vivo
-
Repurposing itraconazole and pyrimethamine with temozolomide as a combinatorial treatment for glioblastoma
(2024) Abstracts from the 19th Meeting of the European Association of Neuro-Oncology. 26(Supplement 5). -
- Journal Article
- A1
- open access
Mapping bacterial extracellular vesicle research : insights, best practices and knowledge gaps
-
Single tumour, many faces : unraveling intratumour complexity of soft tissue sarcoma
-
- Journal Article
- A1
- open access
Minimal information for studies of extracellular vesicles (MISEV2023) : from basic to advanced approaches